Ken Griffin Stevanato Group S.P.A. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$17.98 - $22.02 $21,576 - $26,424	1,200 Added 80.0%	2,700 $54,000
Q2 2024 Aug 14, 2024	SELL	$16.93 - $31.33 $72,799 - $134,719	-4,300 Reduced 74.14%	1,500 $27,000
Q1 2024 May 15, 2024	BUY	$25.34 - $34.28 $78,554 - $106,268	3,100 Added 114.81%	5,800 $186,000
Q4 2023 Feb 14, 2024	BUY	$25.21 - $34.66 $25,210 - $34,660	1,000 Added 58.82%	2,700 $73,000
Q3 2023 Nov 14, 2023	BUY	$26.91 - $35.49 $32,292 - $42,588	1,200 Added 240.0%	1,700 $50,000
Q2 2023 Aug 14, 2023	BUY	$25.15 - $32.86 $12,575 - $16,430	500 New	500 $16,000
Q4 2022 Feb 14, 2023	BUY	$13.95 - $19.28 $153,450 - $212,080	11,000 New	11,000 $197,000

132

55.2M

2.7K

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $5.7B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.